(, Thu 4 Jun 2026, 20:21, Reply)
unlicensed topical formulation applied to a corneal graft (the patient's third) to treat Candida duobushaemulonii is unlikely to cause hepatic problems, it's almost as if AI summaries are less reliable than actual humans
(, Thu 4 Jun 2026, 20:33, Reply)
not sure if that confirms or refutes my point.
(, Thu 4 Jun 2026, 20:35, Reply)
(, Thu 4 Jun 2026, 21:19, Reply)
This infection is resistant to all the usual treatments, so we make an unlicensed one and hope it works or she loses her eye. I don't love all aspects of my job, but there's not much arguing with that. Fingers crossed it works.
(, Thu 4 Jun 2026, 21:25, Reply)